City

Aurora (1)

Boston (1)

Charlottesville (1)

Harrison (1)

Madison (1)

Middletown (1)

New York (1)

Oklahoma City (1)

Rochester (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

biopsy (1)

biospecimen collection (1)

computed tomography (1)

magnetic resonance imaging (1)

multi-epitope folate receptor alpha-loaded dendritic cell vaccine (1)

pegylated liposomal doxorubicin hydrochloride (1)

pembrolizumab (1)

peposertib (1)

pheresis (1)

Study Documents

Intervention Type

biological (1)

drug (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

recurrent ovarian carcinosarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

Not yet recruiting

Fallopian Tube Carcinosarcoma
+14 more

Biopsy
+6 more

Rochester, Minnesota

Mayo Clinic in Rochester

Jun 28, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting

Fallopian Tube Carcinosarcoma
+28 more

Pegylated Liposomal Doxorubicin Hydrochloride
Peposertib

Aurora, Colorado
+7 more

Sep 2, 2022